The exacerbating effect of infectious bronchitis virus infection on the infectious bursal disease virus-induced suppression of opsonization by Escherichia coil antibody in chickens.
Chickens infected with infectious bronchitis virus (IBV) and infectious bursal disease virus (IBDV) commonly develop secondary infection of the respiratory tract with Escherichia coli, resulting in significant economic losses. To understand the host factors that may contribute to the E. coli infection, we investigated macrophage-mediated E. coli phagocytosis, intracellular bacterial killing, and development of opsonizing antibody in previously uninfected chickens and in those infected with IBV, IBDV, and IBDV plus IBV. Macrophages from the peripheral blood and the respiratory tracts of chickens infected with IBV or IBDV plus IBV efficiently performed in vitro phagocytosis of E. coli in the presence of positive-control serum (i.e., E. coli antiserum produced in normal chickens). Those macrophages also had adequate bactericidal activity, indicating that IBV and IBDV infections had not affected their phagocytic activity or bactericidal function. The phagocytic activity of macrophages remained unaffected (P < 0.05) when the positive-control serum was replaced with E. coli antiserum produced in chickens infected with IBV alone. However, when E. coli antisera raised in IBDV-infected and, especially, that produced in IBDV plus IBV-infected chickens were supplemented, the percentage of phagocytosis and number of bacteria ingested per phagocyte were significantly (P < 0.05) less. These results indicate that although IBDV alone has the potential to markedly reduce opsonizing ability of antibody, this effect is significantly (P < 0.05) exacerbated by IBV infection.
Naqi
S
S
Unit of Avian Medicine, Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA.
Thompson
G
G
Bauman
B
B
Mohammed
H
H
D000818:Animals; D000907:Antibodies, Bacterial / Q000276:immunology*; D018175:Birnaviridae Infections / Q000150:complications / Q000276:immunology / Q000662:veterinary*; D002645:Chickens; D018352:Coronavirus Infections / Q000150:complications / Q000276:immunology / Q000662:veterinary*; D004926:Escherichia coli / Q000276:immunology*; D004927:Escherichia coli Infections / Q000150:complications / Q000276:immunology; D001351:Infectious bronchitis virus; D007243:Infectious bursal disease virus; D008264:Macrophages / Q000276:immunology; D010587:Phagocytosis; D011201:Poultry Diseases / Q000276:immunology* / Q000382:microbiology / Q000821:virology; D013047:Specific Pathogen-Free Organisms
D000907:Antibodies, Bacterial